糖尿病前期之前:非肥胖患者中胰岛素抵抗与心血管代谢风险相关(STOP DIABETES)
STOP DIABETES研究中624例空腹血糖正常、BMI<30、HbA1c<5.7%的非肥胖者接受口服葡萄糖耐量试验,以Matsuda指数<第25百分位定义胰岛素抵抗(IR,n=151)。与按BMI、性别、年龄匹配的胰岛素敏感(IS)者相比,IR者血糖异常和心血管代谢风险指标升高,颈动脉斑块存在、大小和数量更多。
要点
- 该人群中约1/4非肥胖、空腹血糖和HbA1c正常者为胰岛素抵抗。
- IR者60分钟和120分钟血糖升高、收缩压和舒张压升高、甘油三酯升高、HDL胆固醇降低。
- IR者颈动脉斑块存在、大小和数量均高于IS组。
核心结论
- 在该非肥胖、空腹血糖正常且HbA1c<5.7%的人群中,约1/4存在胰岛素抵抗,胰岛素抵抗与多项血糖异常和心血管代谢风险指标相关。
研究设计与样本
- STOP DIABETES研究共1860例患者,其中624例空腹血糖正常、BMI<30且HbA1c<5.7%,均接受口服葡萄糖耐量试验。
- 以Matsuda指数<第25百分位定义胰岛素抵抗(n=151),≥第25百分位为胰岛素敏感(n=473)。
- 将IR者(n=151)与按BMI、性别、年龄匹配的IS者(n=151)比较血糖异常和心血管代谢风险指标。
- 在65例IR者和76例IS者中测量颈动脉内膜中层厚度和颈动脉斑块。
主要发现
- 与匹配IS者相比,IR非肥胖者60分钟血浆葡萄糖升高,60分钟血浆葡萄糖>155 mg/dL的患者比例增加。
- 与匹配IS者相比,IR非肥胖者120分钟血浆葡萄糖升高,并存在未识别的糖耐量受损和2型糖尿病,处置指数降低。
- 与匹配IS者相比,IR非肥胖者收缩压和舒张压升高,血浆甘油三酯升高,高密度脂蛋白胆固醇降低,甘油三酯/HDL比值和高敏C反应蛋白升高。
- IR组颈动脉斑块的存在、大小和数量均高于IS组(65例IR vs 76例IS)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Prior studies have demonstrated glycemic and cardiometabolic risk in the prediabetic state. OBJECTIVE: This work aims to examine if insulin resistance (IR) is associated with markers of glycemic, cardiometabolic, and atherosclerotic risk in nonobese, nonprediabetic individuals compared to insulin-sensitive (IS) individuals matched for body mass index (BMI), sex, and age. METHODS: Of 1860 patients from the STOP DIABETES study, 624 had normal fasting plasma glucose, BMI less than 30, and glycated hemoglobin A1c (HbA1c) less than 5.7%. All received an oral glucose tolerance test. Insulin sensitivity was quantitated using the Matsuda index: less than the 25th percentile equals IR (n = 151) and 25th percentile or greater equals IS (n = 473). Measures of dysglycemia and cardiometabolic risk were compared between IR individuals (n = 151) and a subset of IS individuals who were matched for BMI, sex, and age (n = 151). Carotid intima media thickness and carotid plaque were measured in 65 IR and 76 IS individuals. RESULTS: Compared to matched IS patients, IR nonobese individuals demonstrated increased indicators of glycemic and cardiometabolic risk, including increased 60-minute plasma glucose and percentage of patients with 60-minute plasma glucose greater than 155 mg/dL; increased 120-minute plasma glucose; unrecognized impaired glucose tolerance and type 2 diabetes, decreased disposition index; increased systolic and diastolic blood pressure; elevated plasma triglycerides (TGs); reduced high-density lipoprotein (HDL) cholesterol; increased TGs/HDL ratio, and high-sensitivity C-reactive protein. The presence, size, and number of carotid plaques was greater in the IR group. CONCLUSION: Approximately 1 in 4 nonobese patients in this population with normal fasting glucose and HbA1c were IR. In these nonobese participants, IR was associated with multiple indicators of dysglycemia and cardiometabolic risk.
引用
- Armato J, DeFronzo RA, Abdul-Ghani M, et al. Pre-Prediabetes: Insulin Resistance Is Associated With Cardiometabolic Risk in Nonobese Patients (STOP DIABETES). J Clin Endocrinol Metab. 2025. PMID: 39109850. doi:10.1210/clinem/dgae540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。